Get startedLog in
    Picture of Praxis Precision Medicines logo

    PRAX — Praxis Precision Medicines News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeLarge CapMomentum Trap
    All News

    Brief: Praxis Precision Medicines Announces Rare Pediatric Disease Designation Granted For Relutrigine In Dravet Syndrome

    Picture of Praxis Precision Medicines logoPraxis Precision Medicines
    18/12/2024 13:33
    Dec 18 (Reuters) - Praxis Precision Medicines Inc
 PRAX.O :
    * PRAXIS PRECISION MEDICINES ANNOUNCES RARE PEDIATRIC
DISEASE
DESIGNATION GRANTED FOR RELUTRIGINE IN DRAVET SYNDROME
    * TO INITIATE ALL-DEE TRIAL INCLUDING DRAVET SYNDROME IN
1H2025

Source text:  ID:nGNX19RT4 
Further company coverage:  PRAX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Praxis Precision Medicines

    See all news